UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.397

Sortiert nach

Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial

The lancet oncology, 2016-09, Vol.17 (9), p.1306-1316

2016

Link zum Volltext

Verfügbarkeit prüfen

Cyclic di-GMP-dependent signaling pathways in the pathogenic Firmicute Listeria monocytogenes

PLoS pathogens, 2014-08, Vol.10 (8), p.e1004301-e1004301

2014

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial

European urology, 2014-08, Vol.66 (2), p.243-250

2014

Link zum Volltext

Verfügbarkeit prüfen

Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time

Journal of clinical oncology, 2013-10, Vol.31 (30), p.3800-3806

2013

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

International journal of cancer, 2010-03, Vol.126 (5), p.1166-1176

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

Journal of clinical oncology, 2016-09, Vol.34 (25), p.3005-3013

2016

Link zum Volltext

Verfügbarkeit prüfen

CodY-Mediated c-di-GMP-Dependent Inhibition of Mammalian Cell Invasion in Listeria monocytogenes

Journal of bacteriology, 2018-03, Vol.200 (5)

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial

The lancet oncology, 2014-09, Vol.15 (10), p.1147-1156

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2013-05, Vol.31 (14), p.1740-1747

2013

Link zum Volltext

Verfügbarkeit prüfen

Listeria monocytogenes exopolysaccharide: origin, structure, biosynthetic machinery and c‐di‐GMP‐dependent regulation

Molecular microbiology, 2015-05, Vol.96 (4), p.728-743

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95

Journal of clinical oncology, 2009-06, Vol.27 (18), p.2924-2930

2009

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer detection on transrectal ultrasonography‐guided random biopsy despite negative real‐time magnetic resonance imaging/ultrasonography fusion‐guided targeted biopsy: reasons for targeted biopsy failure

BJU international, 2016-07, Vol.118 (1), p.35-43

2016

Link zum Volltext

Verfügbarkeit prüfen

Prostate-Specific Antigen Persistence After Radical Prostatectomy as a Predictive Factor of Clinical Relapse-Free Survival and Overall Survival: 10-Year Data of the ARO 96-02 Trial

International journal of radiation oncology, biology, physics, 2015-02, Vol.91 (2), p.288-294

2015

Link zum Volltext

Verfügbarkeit prüfen

Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients

Retrovirology, 2009-10, Vol.6 (1), p.92-92, Article 92

2009

Link zum Volltext

Verfügbarkeit prüfen

Achieving an Undetectable PSA After Radiotherapy for Biochemical Progression After Radical Prostatectomy Is an Independent Predictor of Biochemical Outcome—Results of a Retrospective Study

International journal of radiation oncology, biology, physics, 2009-03, Vol.73 (4), p.1009-1016

2009

Link zum Volltext

Verfügbarkeit prüfen

Comorbidity and healthcare utilization in patients with treatment resistant depression: A large-scale retrospective cohort analysis using electronic health records

Journal of affective disorders, 2023-03, Vol.324, p.102-113

2023

Link zum Volltext

Verfügbarkeit prüfen

miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome

The Journal of molecular diagnostics : JMD, 2013-09, Vol.15 (5), p.695-705

2013

Link zum Volltext

Verfügbarkeit prüfen

Primary magnetic resonance imaging/ultrasonography fusion‐guided biopsy of the prostate

BJU international, 2018-08, Vol.122 (2), p.211-218

2018

Link zum Volltext

Verfügbarkeit prüfen

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

BMC cancer, 2019-01, Vol.19 (1), p.12-12, Article 12

2019

Link zum Volltext

Verfügbarkeit prüfen

Apalutamid zur Therapie des nichtmetastasierten kastrationsresistenten Prostatakarzinoms

Der Onkologe, 2019-03, Vol.25 (3), p.275-276

Miller, Kurt

2019

Link zum Volltext

Verfügbarkeit prüfen

Regulation of Mannose Phosphotransferase System Permease and Virulence Gene Expression in Listeria monocytogenes by the EIItMan Transporter

Applied and Environmental Microbiology, 2009-11, Vol.75 (21), p.6671-6678

2009

Link zum Volltext

Verfügbarkeit prüfen

Two new species of Hymenochaetaceae from tropical Asia and America

Frontiers in cellular and infection microbiology, 2023-01, Vol.12, p.1100044-1100044

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.397

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.145)
Mit Volltextzugriff
(1.205)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(841)
Life Sciences & Biomedicine
(732)
Humans
(592)
Male
(395)
Biological And Medical Sciences
(271)
Middle Aged
(240)
Female
(239)
Medical Sciences
(224)
Aged
(223)
Adult
(179)
Urology & Nephrology
(170)
Animals
(125)
Oncology
(124)
Nephrology. Urinary Tract Diseases
(106)
Prostate Cancer
(91)
Aged, 80 And Over
(89)
Retrospective Studies
(88)
Urology
(88)
Treatment Outcome
(86)
Physical Sciences
(85)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial

Cyclic di-GMP-dependent signaling pathways in the pathogenic Firmicute Listeria monocytogenes

Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial

Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

CodY-Mediated c-di-GMP-Dependent Inhibition of Mammalian Cell Invasion in Listeria monocytogenes

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial

Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer

Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial

Listeria monocytogenes exopolysaccharide: origin, structure, biosynthetic machinery and c‐di‐GMP‐dependent regulation

Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95

Prostate cancer detection on transrectal ultrasonography‐guided random biopsy despite negative real‐time magnetic resonance imaging/ultrasonography fusion‐guided targeted biopsy: reasons for targeted biopsy failure

Prostate-Specific Antigen Persistence After Radical Prostatectomy as a Predictive Factor of Clinical Relapse-Free Survival and Overall Survival: 10-Year Data of the ARO 96-02 Trial

Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients

Achieving an Undetectable PSA After Radiotherapy for Biochemical Progression After Radical Prostatectomy Is an Independent Predictor of Biochemical Outcome—Results of a Retrospective Study

Comorbidity and healthcare utilization in patients with treatment resistant depression: A large-scale retrospective cohort analysis using electronic health records

miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome

Primary magnetic resonance imaging/ultrasonography fusion‐guided biopsy of the prostate

Pasotuxizumab, a BiTE ® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Apalutamid zur Therapie des nichtmetastasierten kastrationsresistenten Prostatakarzinoms

Regulation of Mannose Phosphotransferase System Permease and Virulence Gene Expression in Listeria monocytogenes by the EIItMan Transporter

Two new species of Hymenochaetaceae from tropical Asia and America

Suchergebnisse filtern